|
The Prostate Cancer Registry: Do patients with metastatic castration-resistant prostate cancer (mCRPC) differ according to metastatic status at diagnosis? |
|
|
Consulting or Advisory Role - Janssen |
Speakers' Bureau - Astellas Pharma; Janssen; Sanofi |
|
|
Consulting or Advisory Role - Astellas Pharma; Janssen; Roche; Sanofi |
Speakers' Bureau - Astellas Pharma; Janssen; Roche; Sanofi |
|
|
Stock and Other Ownership Interests - WntResearch |
Honoraria - Astellas Pharma |
Consulting or Advisory Role - EXINI Diagnostics |
Speakers' Bureau - Astellas Pharma; Bayer Schering Pharma |
Patents, Royalties, Other Intellectual Property - Glactone Pharma |
|
|
Speakers' Bureau - Janssen |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Leadership - Centrum Onkologii Instytutu (I) |
Honoraria - Acraf; Bristol-Myers Squibb; Janssen; MSD; Novartis; Roche |
Consulting or Advisory Role - Acraf; Bristol-Myers Squibb; Janssen; MSD; Novartis; Roche |
Research Funding - Acraf; Bristol-Myers Squibb; Janssen; Merck; MSD; Novartis; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche |
|
|
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Bayer; GlaxoSmithKline; Ipsen; Janssen; Sanofi; Takeda |
Research Funding - Astellas Pharma; Bayer; Janssen |
|
|
Honoraria - AstraZeneca; Janssen; Lilly |
Consulting or Advisory Role - Bayer |
Research Funding - Astellas Pharma; Bayer; Ipsen; Janssen |
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Janssen |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Pfizer; Roche; Sanofi |
Consulting or Advisory Role - Amgen; Pfizer; Roche; Sanofi |
Research Funding - Pierre Fabre; Roche |
Other Relationship - Novartis; Pierre Fabre; Roche; Sanofi |
|
|
|
|
|
Consulting or Advisory Role - Janssen |
|
|
Employment - Janssen-Cilag |
Stock and Other Ownership Interests - Johnson & Johnson |
|
|
|
Stock and Other Ownership Interests - Janssen |